Although our findings were a novel approach to evaluate risk assessment of cognitive impairment after SAH in Hp subgroups, these results could be underpowered or could overestimate risks due to the relatively small sample size compared to those of other wPRS models for coronary artery disease or stroke [30,35]. The gene discussed is HP; the disease is coronary artery disorder.